About Klinikum Lüdenscheid
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Ulm
5
Abbott Medical Devices
4
Boehringer Ingelheim
3
German High-Grade Non-Hodgkin's Lymphoma Study Group
3
Bayer
2
European Organisation for Research and Treatment of Cancer - EORTC
2
German CLL Study Group
2
LivaNova
2
Medtronic Cardiac Rhythm and Heart Failure
2
Stichting Hemato-Oncologie voor Volwassenen Nederland
2
University Hospital Freiburg
2
Clinical Trials at Klinikum Lüdenscheid
During the past decade, Klinikum Lüdenscheid conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on
average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
2001-05-01
Completed
608
Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome
2002-05-01
Unknown status
220
Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
2003-09-01
2005-10-01
Completed
206
Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia
2005-11-01
2011-03-01
Completed
195
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
2005-11-01
2018-02-01
Completed
700
Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
2005-11-01
2018-08-01
Completed
592
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Avoid DeliVering TherApies for Non-sustained Arrhythmias in ICD PatiEnts III
2008-03-01
2012-02-01
Completed
1,902
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinikum Lüdenscheid" #1 sponsor was "University of Ulm" with 5 trials, followed by "Abbott Medical Devices" with 4 trials
sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials sponsored and "Bayer"
with 3 trials sponsored. Other sponsors include 21 different institutions and
companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Lüdenscheid"
#1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator and "Central European Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were
collaborators in the rest 27 trials.
Clinical Trials Conditions at Klinikum Lüdenscheid
According to Clinical.Site data, the most researched conditions in "Klinikum Lüdenscheid" are
"Heart Failure" (9 trials), "Acute Myeloid Leukemia" (6 trials), "Atrial Fibrillation" (6 trials), "Acute Myeloid Leukemia (AML)" (3 trials) and "Lymphoma" (3 trials). Many other conditions were trialed in "Klinikum Lüdenscheid" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Lüdenscheid
Most popular intervention types in "Klinikum Lüdenscheid" are "Drug" (23 trials), "Device" (11 trials), "Other" (6 trials), "Biological" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Cytarabine" (3 trials), "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials) and "prednisone" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Lüdenscheid
The vast majority of trials in "Klinikum Lüdenscheid" are
43 trials for "All" genders.
Clinical Trials Status at Klinikum Lüdenscheid
Currently, there are NaN active trials in "Klinikum Lüdenscheid".
undefined are not yet recruiting,
7 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 29 completed trials in Klinikum Lüdenscheid,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Lüdenscheid, 1 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 15 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 8 trials that are defined as “Not Applicable".